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Background: Fragile X syndrome (FXS) results from a trinucleotide repeat expansion (full mutation >200
cytosine-guanine-guanine (CGG) repeats) in the FMR1 gene, leading to a reduction or absence of the gene’s protein
product, fragile X mental retardation protein (FMRP), ultimately causing cognitive and behavioral impairments that
are characteristic of the syndrome. In our previous work with infants and toddlers with FXS, we have been able
to describe much about their cognitive and visual processing abilities. In light of recent work on the mild cognitive
deficits and functional and structural brain differences that are present in adults with the fragile X (FX) premutation,
in the present study we examined whether some of the low-level visual processing deficits we have observed
in infants with FXS would also be present in infants with the FX premutation (55–200 CGG repeats).
Methods: We chose a contrast detection task using second-order motion stimuli on which infants with FXS previously
showed significantly increased detection thresholds (Vision Res 48:1471–1478, 2008). Critically, we also included a
developmental delay comparison group of infants with Down syndrome (DS), who were matched to infants with
FXS on both chronological and mental age, to speak to the question of whether this second-order motion processing
deficit is a FX-specific phenomenon.
Results: As reported previously, infants with the FX full mutation showed motion contrast detection threshold levels
that were significantly higher than age-matched typically developing control infants. Strikingly, the motion detection
contrast levels of FX premutation infants were also significantly higher than typically developing (TD) infants and not
significantly different from the group of infants with FXS or with DS.
Conclusions: These results, which are in keeping with a growing body of evidence on the mild cognitive and
perceptual processing deficits and functional and structural brain differences that are present in adults and
older children with the FX premutation, underscore the pressing need to study and describe the processing
capabilities of infants and toddlers with the FX premutation.
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Fragile X syndrome (FXS) is the most common inherited
cause of mental disability, which results from a reduc-
tion or absence of the fragile X mental retardation pro-
tein (FMRP), a gene product known to play an essential
role in brain structure and function [1,2]. This condition
emerges when the repeat expansion of the trinucleotide* Correspondence: srivera@ucdavis.edu
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unless otherwise stated.cytosine-guanine-guanine (CGG) in the 5′ untranslated
region of the FMR1 gene, located in the X chromosome,
is above 200 repeats. When this occurs, the FMR1 gene
is typically fully methylated, which prevents the tran-
scription and the translation of the gene, consequently
disrupting the production of FMRP and leading to cas-
cading cognitive and behavioral impairment, including
mild to severe intellectual disability, social anxiety, math
and spatial reasoning problems, and relatively high co-
morbidity with autism (30% of all FXS cases) [3,4]. The
number of individuals with FXS (full mutation >200 CGG)
ranges approximately between 1 per 2,500 in females to 1
per 4,000 in males [5].l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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considered to be premutation carriers of FXS, a condition
more commonly found in the general population, affecting
approximately 1 in 130–250 women and 1 in 250–810
males [5]. Individuals in the premutation range typically
have normal intellectual functioning, but may have ele-
vated FMR1 mRNA, in some cases three to eight times the
normal levels [6]. This elevated mRNA is thought to pro-
duce RNA toxicity, which has been associated with mild
deficits in working memory [7], memory encoding [8],
memory recall [9], enumeration [10], and increased psychi-
atric symptoms including obsessive-compulsive symptoms
and psychoticism [11]. In addition, male premutation car-
riers, especially, are at risk of developing the late-onset
neurodegenerative disorder known as fragile X-associated
tremor/ataxia syndrome (FXTAS) [7,12].
There is now ample evidence that young children with
FXS have significant visual-spatial impairments. For
example, studies of infants and toddlers with FXS have
documented impairments in processing texture-defined
(second order) motion stimuli [13], temporal flicker [14],
perceiving the ordinality of sequences of numerical dis-
plays [15], and the ability to maintain the identity of
dynamic object information during occlusion [16]. Im-
paired performance has also been demonstrated on tasks
requiring visual-motor responses [17,18] as well as in-
hibitory control [19] and numerical reasoning [20,21].
One purported cause of the visual-spatial and numerical
deficits seen in FXS is disruption of the so-called dorsal
stream (the occipito-parietal visual pathway, projecting
to the posterior parietal cortex, which processes infor-
mation involved in guiding actions, including spatial lo-
cation and motion) with relative sparing of the ventral
stream (the occipito-temporal visual pathway, projecting
to the inferior-temporal cortex, which processes object
features such as form and color) [22,23]. Because of its
relatively protracted time course of development [24],
the dorsal stream is thought to be particularly vulnerable
to atypical development in a number of disorders, in-
cluding in FXS [16,25].
Compared to young children with the fragile X full
mutation (FXS), very little is understood about the cog-
nitive and visual processing abilities in young children
with the fragile X (FX) premutation. Recent work on the
mild cognitive deficits and functional and structural
brain differences that are present in adults with the
FX premutation [7,8,10,11,26] and particularly studies
which have documented deficits in visuospatial [27,28]
and contrast sensitivity [29] in adult premutation carriers
led us in the present study to examine whether one
of the low-level visual processing deficits that has been
observed in infants with FXS is also present in infants
with the FX premutation. To study this, we chose a
contrast detection task using second-order motionstimuli on which infants with FXS demonstrated signifi-
cantly increased detection thresholds [13]. We hypothe-
sized that infants and toddlers with the premutation
would perform similarly to infants and toddlers with the
full mutation, i.e., the threshold necessary for detection
of visual stimuli would be higher than typically develop-
ing mental and chronological age-matched controls and
would not be significantly different from participants
with the full mutation. We also included a comparison
group of infants with Down syndrome, who are matched
with the FX full mutation group on both mental and
chronological age, allowing us to examine whether defi-
cits seen in second-order motion processing are specific
to the FX-specific spectrum.
Methods
Participants
Four groups of participants were enrolled in this study:
16 typically developing infants (7 male and 9 female,
mean age 13.17 months), 12 premutation carrier infants
(8 males and 4 females, mean age 17.56 months), 24
infants with FXS (19 male and 5 female, mean age
29.24 months), and 15 infants with Down syndrome
(5 males and 10 females, mean age 26.27 months). A
one-way ANOVA confirmed that the groups signifi-
cantly differed in their chronological age (F(3, 63) = 6.67,
p = 0.001). Simple effect analyses revealed that there was
no significant difference in chronological age (in months)
between typically developing (TD) infants (M = 13.17;
SD = 7.91) and infants with the FX premutation (M = 17.56;
SD = 12.57; t [26] = 1.13, p = 0.27) nor between infants with
Down syndrome (DS) (M = 26.27; SD = 11.95) and FXS
(M = 29.24; SD = 14.35; t [30] = 0.668, p = 0.51). By con-
trast, both the DS and FXS were significantly chrono-
logically older than TD infants (t [31] = 4.07, p = 0.002;
t [29] = 3.62, p = 0.001, respectively.) For infants with
the FX premutation, repeat sizes ranged from 55 to
181, with a mean length of 94. For infants with FXS,
CGG repeat sizes ranged from 210 to 702, with a mean
length of 466.
Participants with FXS were recruited and clinically eval-
uated at the UC Davis MIND Institute. Four participants
with the FX premutation were seen as patients at the UC
Davis M.I.N.D. Institute Fragile X Research and Treatment
Center (FXRTC), while eight were recruited through a
newborn screening project in which parents in the gen-
eral population could consent to screen their newborn
infants for metabolic abnormalities and other preexist-
ing conditions [32]. This recruitment combination al-
lows us to have a sample of premutation infants that is
more representative of the population because parents
who enroll in the newborn screening program are un-
aware of their child’s preexisting condition and therefore
do not present the ascertainment bias that may occur in
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sources for their child. Participants with DS were recruited
from the community by attending outreach events. Typic-
ally developing infants were recruited through letters to
families, fliers, and word of mouth.
Participants were developmentally age-matched using
the Mullen Scales of Early Learning [33], a standardized
developmental assessment used for children 3–60 months
consisting of 5 subscales: gross motor, fine motor, visual
reception, expressive language, and receptive language.
The mental age of each participant was calculated by aver-
aging across the four different domains (VR, FM, RL,
and EL) and converting that average to age in months
and days. The gross motor subscale was omitted from
the mental age calculation as the scores become less valid
in children above the age of 33 months [33]. The mean
mental age was 13.22 months for typically developing
participants, 15.10 months for premutation carriers,
18.01 months for participants with FXS, and 14.13 for
participants with DS. A one-way ANOVA confirmed
that mental age did not differ significantly between the
four groups (F(3,63) = 0.850, p = 0.472). Table 1 depicts
the averaged ELC score across the four groups. A one-
way ANOVA confirmed that the ELC scores, as ex-
pected, differed significantly between the four groups
(F(3,63) = 29.67, p = 0.000). Post hoc analyses show that
there is no significant difference between the participants
with the premutation and typically developing group
when using Bonferroni-corrected values (p = 0.094), sug-
gesting that these two groups are performing at an over-
all comparable cognitive level.
Apparatus and stimuli
A Tobii 1750 binocular eye tracker monitor (Tobii
Technology, Danderyd Sweden, www.tobii.com) was used
to present the visual stimuli. This eye tracking system
consists of a high-resolution camera that records the
eye position, embedded in a 17-in. monitor (1,280 by
1,024 pixel resolution, 50-Hz refresh rate) with infrared
light-emitting diodes that illuminate the cornea, cap-
turing and tracking eye movements that are then run
through proprietary algorithms that calculate changes
in eye position. The visual angle subtended by the dis-
play was 31.63° by 25.36° region on the screen whenTable 1 Mean scores of the early learning composite
scores of the Mullen across groups




FXS 65.61viewed from a distance of 60 cm. The data are captured
at a frame rate of 50 Hz and sent to Tobii Studio (version
2.0.8) to be overlaid on the stimuli. The stimuli used for
this study was generated using The Vision Shell PPC pro-
gram, controlled by an Apple G4 Power Macintosh with
OS9 (Apple, Cupertino, CA, USA). Please see Farzin
et al. [13] for a detailed description of the second-order
(texture-defined) motion (4 Hz) sine wave gratings stim-
uli used in this study.
Procedure
The Institutional Review Board at the University of
California, Davis, approved the experimental protocol,
and an informed consent was obtained from the parents
of all infants. The infants were tested while seated on a
caregiver's lap and were positioned so that their face was
approximately 60–70 cm in front of the eye tracker. In
order to attract the participants' attention to the screen,
room lights were dimmed and an attention-getter video
was displayed on the screen. During this time, an experi-
menter monitored the participant's eye position using a
real-time track-status monitor. If the participant's eyes
were not found, adjustments were made (repositioning
the participant or angling the monitor to adjust for the
participant's height) until a track status was obtained on
both eyes.
Once the participant's eyes were detected by the eye
tracker, a five-point calibration routine was executed in
Tobii Studio. If all points were acquired, the calibration
was saved and the stimulus presentation would begin. If
the calibration was not successful (i.e., not all five points
were acquired), another calibration was attempted. The
minimum criterion required to proceed with the task
was a successful calibration of the center point for each
eye. This ensured that the gaze mapped correctly onto
the stimuli and our areas of interest on the left or the
right side of the screen. The following numbers repre-
sent the participant that could not be calibrated across
the groups: nine FXS, five DS, three PRE, and zero TYP.
These numbers fall within the average range in our lab's
experience for these populations and these ages [13-16].
A forced-choice preferential looking procedure was
utilized [34] in which stimuli were presented either on
the left or the right side of the screen (see Figure 1) Each
trial was approximately 3 s in length, with 1 s of the
grating fading in (500 ms) and out (500 ms) of the
screen. An attention getter was presented between trials
to draw the participants' attention to the middle of the
screen. This attention getter was a colorful, centrally lo-
cated circle looming in and out accompanied by a single
3-s tone. Trials began automatically after the presenta-
tion of the attention getter. The presentation included
four contrast levels (10%, 21%, 31%, or 42%), with the
lowest contrast being the most difficult to perceive and
Figure 1 Schematic example of visual stimuli used. Second-order,
texture-defined moving gradients. Arrow indicates direction of motion.
Example shown is at a contrast level of 42%.





TD DS PRE FXS
1 7 1 3 4 15
2 6 8 2 5 21
3 0 1 2 4 7
4 2 5 4 11 22
Total 15 15 11 24 65
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were a total of 40 trials (10 at each contrast level). The side
of the screen that presented the stimuli was counterba-
lanced, and the contrast level randomized, across trials.
Following the same procedure used in Farzin et al.
[13] after data acquisition at a frame rate of 50 Hz in
Tobii Studio, a video recording of the stimuli overlaid
with the eye tracking gaze data was exported to AVI
format at 30 frames per second and imported into
Noldus Observer 5.0 software (Noldus, Wageningen, The
Netherlands) for manual coding. The coding protocol
tracked gaze location (left, right, away, and center) on
each trial. Center was defined as a fixation that was 50%
on the left and 50% on the right of the midline of the
screen. Coders were blind to the group status of the par-
ticipant, and the inter-rater reliability for manual coding
in Noldus was 97% (40 items; α = 0.97). Correct and in-
correct visual responses were computed per trial, and a
visual preference (VP) score was calculated at each con-
trast level. Correct looking was defined as looking to the
half of the screen with the textured-defined gradient
while incorrect looking was defined as looking at the side
of the screen with the equiluminant gray display. The vis-
ual preference score was defined as the total looking time
to the stimuli (correct looking)/the total looking time
(correct and incorrect looking).
Contrast detection threshold for each participant was
defined by calculating the visual preference score at each
Michelson contrast level (10%, 21%, 31%, and 42%) and
identifying the level (1-4) at which the participant could
detect the stimuli on the screen. Visual preference scoresof 75% or higher were used as a benchmark to deter-
mine the individual stimulus detection threshold. This
benchmark was used in order to replicate the original
contrast detection paper [13] and previous research in
the adult vision literature [34-36]. Seventeen infants
(one TD, four premutation, four DS, and eight FXS) did
not reach a minimum preference score of 75% even at
the highest contrast level. For analytic purposes, these
infants were assigned a score of “4” along with those
who reached a visual preference score of 75% or higher
on only the highest contrast level. Thus, a contrast de-
tection level score of 4 was given to those infants who
could reliably see the gradient stimuli only at the con-
trast level of 42% or (theoretically) higher. Two infants
(1 TD and 1 premutation) were excluded from the ana-
lyses because their preference scores were less than 50%
across all contrast levels.
Results
We carried out an ordered logistic regression to examine
whether individuals in the various diagnostic groups
have different probabilities of obtaining stimulus detec-
tion threshold levels at each of the four levels. In our
analyses, diagnosis consisted of four groups (1 = TD;
2 = DS; 3 = FX premutation; and 4 = FXS) and contrast
detection threshold level was an ordinal variable with
four categories (1 = 10%; 2 = 21%; 3 = 31%; and 4 = 42%
or higher), with percentages representing the amplitude
of the second-order sinusoidal contrast modulation [13].
Our sample size consisted of N = 65 individuals. The dis-
tribution of individuals in each group as a function of the
contrast detection threshold level is reported in Table 2
and depicted graphically in Figure 2.
The criteria used to determine a valid trial was based
on fixations defined by the Clearview Fixation Filter
(Tobii Technology; 35 velocity threshold and 100 dur-
ation threshold), defined by a minimum of a single fix-
ation to either the left or the right side of the screen.
The percentage of the total number of trials that were
deemed valid across the groups (TYP, PRE, DS, and FXS)
were 94%, 95%, 95%, and 90%, respectively. A 4 × 4












TD DS PRE FULL 
% at level 4 
% at level 3 
% at level 2 
% at level 1 
Figure 2 Percentage of infants at each contrast detection threshold level [1-3,13] across the four participant groups.
Table 3 Confidence interval for odds ratio for each group
comparison
Wald confidence interval for odds ratios
Estimate 95% confidence limits
Group 1 vs 2 4.476 1.145 17.500
Group 1 vs 3 4.115 0.948 17.852
Group 1 vs 4 6.621 1.866 23.498
Group 2 vs 3 0.919 0.223 3.785
Group 2 vs 4 1.479 0.453 4.834
Group 3 vs 4 1.609 0.435 5.949
Group 1 = TD, group 2 = DS, group 3 = FX premutation, group 4 = FXS.
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and no significant group by threshold interaction F(3,
189) = 1.118, p = 0.343 interaction.
The various tests of the overall model were all signifi-
cant, indicating that using diagnosis when predicting the
probabilities of the contrasts was reasonable, as com-
pared with a model without diagnosis (χ2 [2] = 8.78,
p = 0.03). The estimates for DS, FX premutation, or FXS
were significant, denoting that belonging to any of these
groups was associated with a lower probability of having a
lower stimulus contrast detection threshold level, relative
to the TD group, which served as the reference. For ex-
ample, the estimate for DS was (β = −1.499, p = 0.031) in-
dicating that, relative to the TD group, individuals in the
DS group have a decrease of 1.5 in the odds of being in a
lower level of contrast. The estimates for the premutation
and FXS groups showed the same pattern (β = −1.417,
p = 0.058; and β = −1.89, p = 0.003, respectively).
The proportional odds ratios (coefficients exponentiated)
show the assignment of contrast detection threshold level
across the groups in terms of odds. For example, the
odds ratio of TD vs. DS is 4.476, suggesting that indi-
viduals in the TD group are 4.5 times more likely to
obtain a lower contrast detection threshold level than
those in the DS group. The odds ratio comparing TD
with FX premutation and with FXS denote that individ-
uals in the TD groups are 4.1 and 6.6 times more likely
to obtain a lower contrast detection threshold level than
individuals in the FX premutation group or the FXS
group, respectively. The odds ratios for these comparisons
are displayed in Table 3, including the 95% confidence
limits of the odds ratios. Figure 3 represents the predictedprobabilities associated with scoring on each category of
the contrast across the four groups.
Discussion
The primary aim of this study was to provide a better
understanding of the low-level visual processing mecha-
nisms present in infant and toddler carriers of the FX
premutation. Using a stimulus detection task for which
we had previously demonstrated visual impairment
(reduced contrast sensitivity) in infants with FXS [13], we
hypothesized that although the phenotypic outcome of
FX premutation carriers is much more favorable than
those with FXS, this deficit in low-level visual processing
would nonetheless be present. Our results confirmed
that FX premutation carriers shared the same likelihood
as full mutation carriers of having a contrast detection
threshold level that was significantly higher (indicating
poorer performance) than typically developing infants
TD DS FX PRE FXS
Threshold Level
Figure 3 Predicted probabilities for contrast detection threshold level. Predicted probabilities for contrast detection threshold level [1-3,13]
in the four participant groups.
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group of infants with DS who were both chronologically
and mentally age-matched to the participants with FXS
and mentally age-matched to the infants with the FX
premutation, and found that their performance did not
differ significantly from the two FX groups. This result is
consistent with research showing that individuals with
DS exhibit significantly reduced visual acuity and con-
trast sensitivity as compared to TD controls [37] and
suggests that this deficit may not be specific to the FX
spectrum but a more general deficit found in other de-
velopmental disabilities such as Williams syndrome and
autism spectrum disorders [30,38].
While it was long believed that individuals with the FX
premutation remained cognitively unaffected throughout
adulthood, there have been a number of studies, particu-
larly those utilizing brain imaging techniques, which have
documented measurable differences in brain functioning,
across a number of different cognitive domains, in young
adult premutation carriers who are asymptomatic for
FXTAS [7,8,26]. Adult male FX premutation carriers have
also been shown to exhibit slower reaction times, even
after controlling for simple reaction time, in the visuo-
spatial tasks of magnitude comparison and enumeration
[28]. Perhaps most relevant to the present study, a recent
investigation has shown that adult female FX premutation
carriers show a ‘dorsal stream deficit’ in that they are
selectively impaired on perceptual tests of magnocellular(so-called M pathway—projecting primarily to dorsal visual
stream areas) stimuli, whereas they show intact perform-
ance on tests of parvocellular (‘P pathway’—projecting pri-
marily to ventral visual stream areas) stimuli [29].
The present study is unique in that it is the first to
document dorsal stream processing difficulties in infants
and toddlers with the FX premutation. Our results sug-
gest that even in very young premutation carriers, who
in the vast majority of cases are cognitively unaffected
and developing normally, a selective visual motion pro-
cessing impairment on second-order motion gradient
stimuli is present that is not significantly different from
that found in those with the FX full mutation. While
these results are striking, they beg the important ques-
tion of what is the functional importance of such an im-
pairment. It may be, as suggested by Keri and Benedek
[29], that this represents a psychophysical endophe-
notype (a marker of genetic traits that do not result
in observable clinical symptoms) for the FX spectrum of
involvement. If so, individual differences in this ability
may hold clues for differentiating those individuals on
the FX spectrum (which includes premutation carriers,
mosaics, and full mutation individuals) who are at risk
for developing more severe phenotypes.
As reviewed above, there have been numerous demon-
strations of spatiotemporal deficits in both individuals
with FXS and those with the FX premutation. Because
representations of space and time are integral to forming
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spatiotemporal processing may in fact also underlie the
impairments in numerical processing that have been ob-
served in both FXS [21] and in FX premutation carriers
[26,39]. In females with FXS, brain activation during
arithmetic processing has also been shown to be related
to FMRP expression [21], which suggests that impaired
processing of spatiotemporal information that is medi-
ated primarily by the parietal cortex may represent an
endophenotype that is modulated by FMR1 gene expres-
sion across the FX spectrum. While the present study
was underpowered to study how second-order motion
visual processing may be modulated by variations in
FMR1 gene expression, this is an important question for
future research to address.
Despite the spatiotemporal processing impairments in
individuals with the FX premutation demonstrated both
in the present study and elsewhere [28,29], the fact
remains that individuals with the FX premutation only
rarely present with overall cognitive functioning that
falls below the normal range. One might be tempted,
then, to dismiss these low-level visual processing impair-
ments as unimportant to the individual’s perceptual and
cognitive development. However, the presence of such
impairments, even in an individual whose overall cogni-
tive development falls within the normal range, may
force compensation in the developing neural system,
thus changing the landscape of development in ways
that are difficult to measure, though potentially still
impactful. It is therefore imperative that we continue to
study and broaden our understanding of the processing
capabilities of individuals with the FX premutation, par-
ticularly early in life.
Conclusions
We tested four groups of infants and toddlers (TD, DS,
FX premutation, and FXS) on a second-order motion
stimulus detection task for which we had previously dem-
onstrated visual impairment (reduced contrast sensitivity)
in infants with FXS [13]. As reported previously, infants
with FXS showed motion contrast detection threshold
levels that were significantly higher than age-matched typ-
ically developing control infants. Strikingly, the motion de-
tection contrast levels of FX premutation infants were also
significantly higher than TD infants, and not significantly
different from the group of infants with FXS or with the
DS group. The present data, along with other evidence of
impairments in processing spatiotemporal information
that comes from the study of adults with the FX premuta-
tion, suggest that this type of spatiotemporal processing
impairment may constitute an endophenotype for indi-
viduals on the FX spectrum and highlights the need for
further study of the development of these processes, espe-
cially in children with the FX premutation.Abbreviations
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